44 related articles for article (PubMed ID: 16935897)
1. Inhibition of Human Neutrophil Functions In Vitro by Multiple Sclerosis Disease-Modifying Therapies.
Scutera S; Musso T; Cavalla P; Piersigilli G; Sparti R; Comini S; Vercellino M; Cuffini AM; Banche G; Allizond V
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33147889
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up characteristics of patients with anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) receiving chronic hemodialysis at a single center.
Miyabe Y; Karasawa K; Takabe T; Ogura S; Sugiura N; Kyoda M; Ono W; Akiyama K; Tanaka N; Moriyama T; Hanafusa N; Uchida K; Tuchiya K; Nitta K
Clin Exp Nephrol; 2020 Feb; 24(2):136-142. PubMed ID: 31641958
[TBL] [Abstract][Full Text] [Related]
3. Free and total p-cresol sulfate levels and infectious hospitalizations in hemodialysis patients in CHOICE and HEMO.
Banerjee T; Meyer TW; Shafi T; Hostetter TH; Melamed M; Zhu Y; Powe NR
Medicine (Baltimore); 2017 Feb; 96(6):e5799. PubMed ID: 28178126
[TBL] [Abstract][Full Text] [Related]
4. Dialyzer Reuse and Outcomes of High Flux Dialysis.
Argyropoulos C; Roumelioti ME; Sattar A; Kellum JA; Weissfeld L; Unruh ML
PLoS One; 2015; 10(6):e0129575. PubMed ID: 26057383
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of neutrophil function during hemodialysis treatment in healthy dogs under anesthesia with sevoflurane.
Shimamura S; Kimura K; Katayama M; Mashita T; Maeda K; Kobayashi S; Sato R; Yasuda J
J Vet Med Sci; 2014 Nov; 76(11):1539-43. PubMed ID: 25141879
[TBL] [Abstract][Full Text] [Related]
6. Activation of basophils is a new and sensitive marker of biocompatibility in hemodialysis.
Aljadi Z; Mansouri L; Nopp A; Paulsson JM; Winqvist O; Russom A; Ståhl M; Hylander B; Jacobson SH; Lundahl J
Artif Organs; 2014 Nov; 38(11):945-53. PubMed ID: 24712758
[TBL] [Abstract][Full Text] [Related]
7. Leukocyte proliferation and immune modulator production in patients with chronic kidney disease.
Mansouri L; Paulsson JM; Moshfegh A; Jacobson SH; Lundahl J
PLoS One; 2013; 8(8):e73141. PubMed ID: 23951343
[TBL] [Abstract][Full Text] [Related]
8. Candida albicans infections in renal transplant recipients: effect of caspofungin on polymorphonuclear cells.
Allizond V; Banche G; Giacchino F; Merlino C; Scalas D; Tullio V; Garneri G; Mandras N; Roana J; Cuffini AM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5936-8. PubMed ID: 21968354
[TBL] [Abstract][Full Text] [Related]
9. Synergy of caspofungin with human polymorphonuclear granulocytes for killing Candida albicans.
Tullio V; Mandras N; Scalas D; Allizond V; Banche G; Roana J; Greco D; Castagno F; Cuffini AM; Carlone NA
Antimicrob Agents Chemother; 2010 Sep; 54(9):3964-6. PubMed ID: 20585121
[TBL] [Abstract][Full Text] [Related]
10. Low-density lipoprotein (LDL) apheresis reduces atherogenic and oxidative markers in uremic patients with hyperlipidemia.
Chen TS; Liou SY; Wu HC; Tsai FJ; Tsai CH; Huang CY; Chang YL
Int Urol Nephrol; 2011 Jun; 43(2):471-4. PubMed ID: 20229247
[TBL] [Abstract][Full Text] [Related]
11. Effects of uraemia and dialysis modality on polymorphonuclear cell apoptosis and function.
Sardenberg C; Suassuna P; Andreoli MC; Watanabe R; Dalboni MA; Manfredi SR; dos Santos OP; Kallas EG; Draibe SA; Cendoroglo M
Nephrol Dial Transplant; 2006 Jan; 21(1):160-5. PubMed ID: 16155068
[TBL] [Abstract][Full Text] [Related]
12. Biocompatibility and risk of infection in haemodialysis patients.
Himmelfarb J; Hakim RM
Nephrol Dial Transplant; 1994; 9 Suppl 2():138-44. PubMed ID: 8065605
[TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of dialysis membrane.
Kes P
Acta Med Croatica; 1999; 53(1):29-40. PubMed ID: 10437275
[TBL] [Abstract][Full Text] [Related]
14. Effect of dialysis membrane biocompatibility on polymorphonuclear granulocyte activity in dialysis patients.
Banche G; Allizond V; Giacchino F; Mandras N; Roana J; Bonello F; Belardi P; Tullio V; Merlino C; Carlone N; Cuffini AM
Nephrol Dial Transplant; 2006 Dec; 21(12):3532-8. PubMed ID: 16935897
[TBL] [Abstract][Full Text] [Related]
15. Phagocytosis activity of polymorphonuclear cells of normal persons and dialysis patients is influenced by different dialysis membranes.
Schauer S; Stein G; Süss J; Falkenhagen D; Linss W
Nephrol Dial Transplant; 1991; 6 Suppl 3():35-40. PubMed ID: 1775265
[TBL] [Abstract][Full Text] [Related]
16. Impact of co-amoxiclav on polymorphonuclear granulocytes from chronic hemodialysis patients.
Cuffini AM; Tullio V; Giacchino F; Mandras N; Scalas D; Belardi P; Merlino C; Carlone NA
Am J Kidney Dis; 2001 Jun; 37(6):1253-9. PubMed ID: 11382696
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
